ArticleBMC public health2025
Association between frailty and frailty change with chronic lung disease: results from two prospective cohort studies.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Epigenetic Signatures of Frailty: A Systematic Review, Meta-Analysis, and Network Analysis of the Chemical Exposome.International journal of molecular sciences · 2026Pooled it
- Association between frailty and the risks of chronic pulmonary diseases and lung cancer.BMC pulmonary medicine · 2026Article
- Frailty Transition and Risk of New-Onset Arthritis Among Adults Aged 45 Years and Older: A Longitudinal Analysis of CHARLS.Healthcare (Basel, Switzerland) · 2026Article
- Development and internal validation of a frailty prediction model in adults aged ≥ 45 years with obesity: evidence from the China Health and Retirement Longitudinal Study (CHARLS).BMC public health · 2026Article
- Frailty, depressive symptoms, and incident respiratory disease: a CHARLS cohort study.BMC pulmonary medicine · 2026Article
- Heterogeneous frailty trajectories and their differential impact on social integration in older adults with COPD: a prospective longitudinal study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe relationship between frailty and frailty change with the risk of chronic lung disease (CLD) among middle-aged and older adults remains unclear. This study explored the associations of frailty and frailty change with CLD based on two prospective cohort studies.
methodsThe data were drawn from the Health and Retirement Study (HRS) and the China Health and Retirement Longitudinal Study (CHARLS). Frailty status was evaluated by the frailty index (FI) and categorized as robust, pre-frail, and frail. FI change was calculated as the difference between the two repeated measurements of FI, and divided into stable FI, gained FI, and decreased FI. Group-based trajectory modeling was adopted to identify the trajectory of FI. Logistic regression models were then performed to estimate the odds ratio (OR) and 95% confidence interval (95% CI) between frailty status, frailty trajectory, and frailty change with the risk of CLD.
resultsA total of 9,178 participants from CHARLS and 11,262 participants from HRS were included. In the full-adjustment model, frail participants had higher risks of CLD compared to robust participants (CHARLS: OR = 2.28, 95% CI = 1.71-3.04; HRS: OR = 2.21, 95% CI = 1.17-4.17). The significantly elevated risks of CLD were also observed in the participants with the high-FI trajectory (CHARLS: OR = 2.11, 95% CI = 1.37-3.26; HRS: OR = 2.15, 95% CI = 1.16-3.97). The participants with decreased FI were at lower risks of CLD in the HRS (OR = 0.58, 95% CI = 0.38-0.87). However, gained FI was related to higher risks of CLD in the CHARLS (OR = 1.38, 95% CI = 1.11-1.72).
conclusionFrail individuals might be related with higher risks of CLD. Moreover, the progression of frailty increased the risk of CLD, while recovery of frailty decreased the risk of CLD. Appropriate interventions aimed at reversion of frailty status may be needed to prevent CLD in current clinical respiratory care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.